| Primary information |
|---|
| sequence ID | Seq_3506 |
| Peptide sequence | HPVLLTEAPLNPK |
| CancerPDF_ID | CancerPDF_ID8943, CancerPDF_ID11587, |
| PMID | 24694173,26992070 |
| Protein Name | "Actin, cytoplasmic 1","Actin, cytoplasmic 2" |
| UniprotKB Entry Name | ACTB_HUMAN,NA |
| Fluid | Ascites fluid,Serum |
| M/Z | NA,1427.8136 |
| Charge | 1,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LTQ-Orbitrap XL,LC-MS |
| Peptide Identification technique | X tandem for peptide identification,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID8943, CancerPDF_ID11587, |
| p-Value | NA,NA |
| Software | "X tandem for peptide identification,Scaffold 2 software for any modification analysis",SEQUEST and Maxquant |
| Length | 13,13 |
| Cancer Type | Ovarian cancer,Melanoma |
| Database | "IPI00021439,IPI00894365,IPI00894498",SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 3 ovarian cancer patient and 3 non cancerous control,8 cancer samples and 4 healthy samples |
| Regulation | Uniquely expressed in ovarian cancer patient,"Present in 1 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 441248
|